Compile Data Set for Download or QSAR
Report error Found 1220 Enz. Inhib. hit(s) with Target = 'Menin'
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 752288BDBM752288(US20250197392, Compound 51a)
Affinity DataIC50: 0.0240nMAssay Description:To an untreated, white 384-well microtiter plate was added 40 nL 200× test compound in DMSO and 4 μL 2× terbium chelate-labeled menin (vide infra for...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 752287BDBM752287(US20250197392, Compound 51)
Affinity DataIC50: 0.0420nMAssay Description:To an untreated, white 384-well microtiter plate was added 40 nL 200× test compound in DMSO and 4 μL 2× terbium chelate-labeled menin (vide infra for...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 689587BDBM689587(US20240261292, Compound A | US20240261292, Compoun...)
Affinity DataIC50: 0.0900nMAssay Description:To an untreated, white 384-well microtiter plate was added 40 nL 200�� test compound in DMSO and 4 uL 2�� terbium chelate-labeled menin (vide infra f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/25/2024
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 689589BDBM689589(US20240261292, Compound A3 | oxalate )
Affinity DataIC50: 0.0980nMAssay Description:To an untreated, white 384-well microtiter plate was added 40 nL 200�� test compound in DMSO and 4 uL 2�� terbium chelate-labeled menin (vide infra f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/25/2024
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 689587BDBM689587(US20240261292, Compound A | US20240261292, Compoun...)
Affinity DataIC50: 0.110nMAssay Description:To an untreated, white 384-well microtiter plate was added 40 nL 200�� test compound in DMSO and 4 uL 2�� terbium chelate-labeled menin (vide infra f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/25/2024
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 689590BDBM689590(US20240261292, Compound A1 | US12473295, Compound ...)
Affinity DataIC50: 0.180nMAssay Description:To an untreated, white 384-well microtiter plate was added 40 nL 200�� test compound in DMSO and 4 uL 2�� terbium chelate-labeled menin (vide infra f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/25/2024
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50516582BDBM50516582(CHEMBL4449381)
Affinity DataKi: <1nMAssay Description:Inhibition of FAM-probe binding to Menin (unknown origin) after 60 mins by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50511905BDBM50511905(CHEMBL4530300)
Affinity DataIC50: 1nMAssay Description:Inhibition of fluorescent labeled tracer binding to Menin (unknown origin) after 1 hr by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 506357BDBM506357(methyl ((1S,2R)-2-((S)-1-(1-((1-(4-((1-((E)-4- (di...)
Affinity DataIC50: 1nMAssay Description:A fluorescence polarization (FP) competitive binding assay was used to determine the binding affinities of representative menin inhibitors. A FAM lab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50454121BDBM50454121(CHEMBL4211366)
Affinity DataIC50: 1nMAssay Description:Displacement of FITC-MBM1 from menin (unknown origin) measured after 1 hr by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50516569BDBM50516569(CHEMBL4585198 | US10899738, Cpd. No 148)
Affinity DataKi:  1nMAssay Description:Inhibition of FAM-probe binding to Menin (unknown origin) after 60 mins by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50489222BDBM50489222(CHEMBL2314822)
Affinity DataKd:  1.40nMAssay Description:Binding affinity to menin (unknown origin) after 60 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50516571BDBM50516571(CHEMBL4592636 | US10899738, Cpd. No 50)
Affinity DataKi:  1.40nMAssay Description:Inhibition of FAM-probe binding to Menin (unknown origin) after 60 mins by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50516570BDBM50516570(CHEMBL4551865 | US10899738, Cpd. No 48)
Affinity DataKi:  1.40nMAssay Description:Inhibition of FAM-probe binding to Menin (unknown origin) after 60 mins by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50516567BDBM50516567(CHEMBL4449199 | US10899738, Cpd. No 51)
Affinity DataKi:  1.70nMAssay Description:Inhibition of FAM-probe binding to Menin (unknown origin) after 60 mins by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50582737BDBM50582737(CHEMBL5076146)
Affinity DataIC50: 1.70nMAssay Description:Binding affinity to menin (unknown origin) incubated for 1 hr by fluorescence polarization-based competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50511899BDBM50511899(CHEMBL4457657 | US11045448, Cpd. No. 67)
Affinity DataIC50: 1.70nMAssay Description:Inhibition of fluorescent labeled tracer binding to Menin (unknown origin) after 1 hr by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50516554BDBM50516554(CHEMBL4522767 | US10899738, Cpd. No 49)
Affinity DataKi:  2nMAssay Description:Inhibition of FAM-probe binding to Menin (unknown origin) after 60 mins by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 506337BDBM506337(methyl ((1S,2R)-2-((S)-(1-((1-(4-((3- acrylamidoph...)
Affinity DataIC50: 2nMAssay Description:A fluorescence polarization (FP) competitive binding assay was used to determine the binding affinities of representative menin inhibitors. A FAM lab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 506340BDBM506340(methyl ((1S,2R)-2-((S)-1-(1-((1-(4-((1-acryloylaze...)
Affinity DataIC50: 2nMAssay Description:A fluorescence polarization (FP) competitive binding assay was used to determine the binding affinities of representative menin inhibitors. A FAM lab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50516568BDBM50516568(CHEMBL4516680)
Affinity DataKi:  2nMAssay Description:Inhibition of FAM-probe binding to Menin (unknown origin) after 60 mins by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 506341BDBM506341(methyl ((1S,2R)-2-((S)-1-(1-((1-(4-((3- acrylamido...)
Affinity DataIC50: 2nMAssay Description:A fluorescence polarization (FP) competitive binding assay was used to determine the binding affinities of representative menin inhibitors. A FAM lab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 506342BDBM506342((1S,2R)-2-((S)-(1-((1-(4-((4- acrylamidophenyl)sul...)
Affinity DataIC50: 2nMAssay Description:A fluorescence polarization (FP) competitive binding assay was used to determine the binding affinities of representative menin inhibitors. A FAM lab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 506346BDBM506346(methyl ((1S,2R)-2-((S)-1-(1-((1-(4-((1-acryloylaze...)
Affinity DataIC50: 2nMAssay Description:A fluorescence polarization (FP) competitive binding assay was used to determine the binding affinities of representative menin inhibitors. A FAM lab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50511912BDBM50511912(CHEMBL4571451)
Affinity DataIC50: 2nMAssay Description:Inhibition of fluorescent labeled tracer binding to Menin (unknown origin) after 1 hr by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50511910BDBM50511910(CHEMBL4450979)
Affinity DataIC50: 2nMAssay Description:Inhibition of fluorescent labeled tracer binding to Menin (unknown origin) after 1 hr by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50511908BDBM50511908(CHEMBL4456003)
Affinity DataIC50: 2nMAssay Description:Inhibition of fluorescent labeled tracer binding to Menin (unknown origin) after 1 hr by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 506354BDBM506354(methyl ((1S,2R)-2-((S)-cyano(1-((1-(4-((3-((E)-4- ...)
Affinity DataIC50: 2nMAssay Description:A fluorescence polarization (FP) competitive binding assay was used to determine the binding affinities of representative menin inhibitors. A FAM lab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50511902BDBM50511902(CHEMBL4553102)
Affinity DataIC50: 2nMAssay Description:Inhibition of fluorescent labeled tracer binding to Menin (unknown origin) after 1 hr by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50511903BDBM50511903(CHEMBL4588924)
Affinity DataIC50: 2nMAssay Description:Inhibition of fluorescent labeled tracer binding to Menin (unknown origin) after 1 hr by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50511899BDBM50511899(CHEMBL4457657 | US11045448, Cpd. No. 67)
Affinity DataIC50: 2nMAssay Description:A fluorescence polarization (FP) competitive binding assay was used to determine the binding affinities of representative menin inhibitors. A FAM lab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50511900BDBM50511900(CHEMBL4454017 | US11045448, Cpd. No. 72)
Affinity DataIC50: 2nMAssay Description:Inhibition of fluorescent labeled tracer binding to Menin (unknown origin) after 1 hr by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50511901BDBM50511901(CHEMBL4528467)
Affinity DataIC50: 2nMAssay Description:Inhibition of fluorescent labeled tracer binding to Menin (unknown origin) after 1 hr by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50511898BDBM50511898(CHEMBL4456868)
Affinity DataIC50: 2nMAssay Description:Inhibition of fluorescent labeled tracer binding to Menin (unknown origin) after 1 hr by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50511900BDBM50511900(CHEMBL4454017 | US11045448, Cpd. No. 72)
Affinity DataIC50: 2nMAssay Description:A fluorescence polarization (FP) competitive binding assay was used to determine the binding affinities of representative menin inhibitors. A FAM lab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 506364BDBM506364(methyl ((1S,2R)-2-((S)-2-(2-ethyl-1H-imidazol-1-yl...)
Affinity DataIC50: 2nMAssay Description:A fluorescence polarization (FP) competitive binding assay was used to determine the binding affinities of representative menin inhibitors. A FAM lab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50516565BDBM50516565(CHEMBL4578509 | US10899738, Cpd. No 92)
Affinity DataKi:  2.40nMAssay Description:Inhibition of FAM-probe binding to Menin (unknown origin) after 60 mins by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50582744BDBM50582744(CHEMBL5085940)
Affinity DataIC50: 2.5nMAssay Description:Binding affinity to menin (unknown origin) incubated for 1 hr by fluorescence polarization-based competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50511904BDBM50511904(CHEMBL4438797)
Affinity DataIC50: 2.60nMAssay Description:Inhibition of fluorescent labeled tracer binding to Menin (unknown origin) after 1 hr by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50516581BDBM50516581(CHEMBL4458829)
Affinity DataKi:  2.70nMAssay Description:Inhibition of FAM-probe binding to Menin (unknown origin) after 60 mins by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50582751BDBM50582751(CHEMBL5094183)
Affinity DataIC50: 2.70nMAssay Description:Binding affinity to menin (unknown origin) incubated for 1 hr by fluorescence polarization-based competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50516574BDBM50516574(CHEMBL4444304 | US10899738, Cpd. No 54)
Affinity DataKi:  2.70nMAssay Description:Inhibition of FAM-probe binding to Menin (unknown origin) after 60 mins by fluorescence polarization competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50582746BDBM50582746(CHEMBL5081367)
Affinity DataIC50: 2.70nMAssay Description:Binding affinity to menin (unknown origin) incubated for 1 hr by fluorescence polarization-based competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50582738BDBM50582738(CHEMBL5071412)
Affinity DataIC50: 2.80nMAssay Description:Binding affinity to menin (unknown origin) incubated for 1 hr by fluorescence polarization-based competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50582747BDBM50582747(CHEMBL5079678)
Affinity DataIC50: 2.80nMAssay Description:Binding affinity to menin (unknown origin) incubated for 1 hr by fluorescence polarization-based competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50582735BDBM50582735(CHEMBL5090509)
Affinity DataIC50: 2.90nMAssay Description:Binding affinity to menin (unknown origin) incubated for 1 hr by fluorescence polarization-based competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50489239BDBM50489239(CHEMBL2314823)
Affinity DataKi:  2.90nMAssay Description:Binding affinity to menin (unknown origin) after 60 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 506335BDBM506335((1S,2R)-2-((S)-(1-((1-(4-((3- acrylamidophenyl)sul...)
Affinity DataIC50: 3nMAssay Description:A fluorescence polarization (FP) competitive binding assay was used to determine the binding affinities of representative menin inhibitors. A FAM lab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50582749BDBM50582749(CHEMBL5079839)
Affinity DataIC50: 3nMAssay Description:Binding affinity to menin (unknown origin) incubated for 1 hr by fluorescence polarization-based competitive binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetMenin(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 50511906BDBM50511906(CHEMBL4435830 | US11045448, Cpd. No. 57)
Affinity DataIC50: 3nMAssay Description:Inhibition of fluorescent probe binding to Menin (2 to 610 residues containing deletion from 460-519) (unknown origin) after 60 mins by fluorescence ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details Article
PubMed
Displayed 1 to 50 (of 1220 total ) | Next | Last >>
Jump to: